Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ocular Therapeutix
AddedFeb 19, 2024
UpdatedJun 18, 2026
Ocular Therapeutix

Ocular Therapeutix

Public

Ocular Therapeutix, Inc.: Global biopharma innovator in hydrogel-based ophthalmic therapies.

HQ
Bedford, MA, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Ocular Therapeutix, Inc. is a biopharmaceutical company founded with the mission to safeguard vision and enhance lives through innovative ophthalmic therapies. Utilizing its proprietary hydrogel technology, the company develops and markets sustained-release drug delivery systems aimed at treating retinal diseases, glaucoma, and other eye conditions. Their products are designed to address unmet and underserved needs in ophthalmology, providing consistent and sustainable treatment options for patients worldwide.

Notable figures associated with Ocular Therapeutix include key investors from prominent venture capital firms specializing in healthcare and biotechnology. The company has achieved significant milestones, such as advancing multiple therapeutic candidates through clinical trials and securing regulatory approvals for its products. Ocular Therapeutix's impact is marked by its commitment to improving patient outcomes and quality of life through cutting-edge ophthalmic solutions.

Ocular Therapeutix - Similar Companies

Ocular Science logo

Ocular Science

ocularscience.com

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

OcuCure Therapeutics logo

OcuCure Therapeutics

EyeCyte logo

EyeCyte

eyecyte.com

Glaukos logo

Glaukos

glaukos.com

Ocumension Therapeutics logo

Ocumension Therapeutics

OcuMedic logo

OcuMedic

Visiox logo

Visiox

visioxpharma.com

Alimera Sciences logo

Alimera Sciences

OcuTerra Therapeutics logo

OcuTerra Therapeutics

ocuterratx.com

EyePoint logo

EyePoint

Surface Ophthalmics logo

Surface Ophthalmics

Vitreoretinal Technologies logo

Vitreoretinal Technologies

TherOptix logo

TherOptix

Visus Therapeutics logo

Visus Therapeutics

visustx.com

Ocular Therapeutix - Quick Facts

Who are Ocular Therapeutix's competitors?

Companies similar to Ocular Therapeutix include Ocular Science, Hyperion DeFi, OcuCure Therapeutics and EyeCyte.

When was Ocular Therapeutix founded?

Ocular Therapeutix was founded in 2006.

Where is Ocular Therapeutix's headquarters located?

Ocular Therapeutix's headquarters is located in Bedford, MA, US.

When was Ocular Therapeutix's last funding round?

Ocular Therapeutix's most recent funding round was for $115.1M (USD) in December 2023.

How much has Ocular Therapeutix raised to-date?

As of Dec 13, 2023, Ocular Therapeutix has raised a total of $386.5M (USD).

How many employees does Ocular Therapeutix have?

Ocular Therapeutix has 274 employees as of Feb 6, 2024.

Ocular Therapeutix - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Ophthalmic Therapies
Tags
  • Biotech
  • Healthtech
Unique IDs
  • ein: 000000000
  • secCik: 0001393434
  • ticker: OCUL
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research